<!--
title: Hormone Blockers
description: 
published: false
date: 2025-06-24T15:23:28.911Z
tags: 
editor: ckeditor
dateCreated: 2025-06-24T15:12:39.012Z
-->

<h1>Hormone Blockers</h1>
<p><a href="https://hrtscience.info/en/26895269_2023_2294321">A retrospective review of the use of bicalutamide in transfeminine youth; a single center experience</a></p>
<p><a href="https://hrtscience.info/en/cen_14329">A systematic review of antiandrogens and feminization in transgender women</a></p>
<p><a href="https://hrtscience.info/en/j_jsxm_2021_05_003">Anti-Androgenic Effects Comparison Between Cyproterone Acetate and Spironolactone in Transgender Women: A Randomized Controlled Trial</a></p>
<p><a href="https://hrtscience.info/en/j_jadohealth_2018_10_296">Bicalutamide as an Androgen Blocker With Secondary Effect of Promoting Feminization in Male-to-Female Transgender Adolescents</a></p>
<p><a href="https://hrtscience.info/en/2024_02_21_24302999">Bicalutamide does not raise transaminases in comparison to alternative anti-androgen regimens among transfeminine adolescents and young adults: a retrospective cohort study</a></p>
<p><a href="https://hrtscience.info/en/clinem_dgae650">Effect of Spironolactone and Cyproterone Acetate on Breast Growth in Transgender People: A Randomized Clinical Trial</a></p>
<p><a href="https://hrtscience.info/en/20420188241305022">Effect of bicalutamide on serum total testosterone concentration in transgender adults: a case series</a></p>
<p><a href="https://hrtscience.info/en/bvaa046_1575">Gonadotropin Releasing Hormone (GnRH) Agonist Therapy Induces a Sustained Reduction in Plasma Testosterone Levels and Is Well Tolerated in Transwomen Veterans</a></p>
<p><a href="https://hrtscience.info/en/clinem_dgab427">Toward a Lowest Effective Dose of Cyproterone Acetate in Trans Women: Results From the ENIGI Study</a></p>
<p><a href="https://hrtscience.info/en/01_hjh_0001063652_84889_bc">Very Low-dose Cyproterone Acetate (12.5 Mg/day) Is Effective As Androgen Blocker; Well Tolerated And Not Associated With Hypertension Development In Young Female Transgender People</a></p>
